Market Overview:
The global third-party medical inspection market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for quality healthcare services and rising awareness about preventive healthcare measures. In addition, the growing number of private hospitals and diagnostic centers is also contributing to the growth of this market. The biochemical inspection segment is expected to account for the largest share of the global third-party medical inspection market in 2018. This segment is mainly driven by increasing demand for advanced diagnostic tests and growing prevalence of chronic diseases such as cancer, diabetes, and heart diseases.
Product Definition:
Third-party medical inspection is a process where an impartial third party reviews the medical records of a patient to ensure that the care provided was appropriate. The importance of third-party medical inspection is that it helps to ensure that patients receive quality care and can help to identify any potential issues with the care provided.
Biochemical Inspection:
In the present scenario, there is a growing demand for third-party medical inspection services. This is due to increasing awareness among consumers and stringent regulations by government organizations.
Immunoassay:
The global immunoassay market is expected to witness significant growth over the forecast period. The major factor attributing to its large share includes an increase in prevalence of infectious diseases coupled with rise in demand for rapid diagnostic tests across the globe.
Moreover, increasing government initiatives and favorable reimbursement policies are also anticipated to boost industry growth during the forecast period from 2015 to 2022.
Application Insights:
The hospital application segment led the market and accounted for more than 60.0% share of the global revenue in 2017. The hospital-based laboratories face several challenges in managing electronic health records (EHRs) and laboratory information systems (LIS), which has resulted in a growing demand for third-party medical inspection services at hospitals. These services help reduce the cost, time, and errors associated with EHRs by providing an external perspective on patient lab tests results to providers.
These services also assist healthcare providers to comply with federal quality standards established by U.S. Department of Health & Human Services through its Office of Inspector General (OIG).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of international and domestic players, high adoption rate of advanced technologies, and increasing government initiatives for improving healthcare standards. For instance, in 2014’s budget proposal for 2015 fiscal year, the U.S Department of Health & Human Services proposed an investment worth USD X million to support public health laboratories that offer testing services at low cost or as free access to patients.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to factors such as rising disposable income; growing target population base; supportive government policies aimed at improving healthcare infrastructure;.
Growth Factors:
- Increasing demand for quality control and assurance in the medical device industry
- Growing number of medical device recalls and product liability claims
- Stringent regulatory requirements for medical devices
- Proliferation of counterfeit medical devices in the global market
- Rising awareness about third-party inspection services among healthcare professionals and consumers
Scope Of The Report
Report Attributes
Report Details
Report Title
Third-party Medical Inspection Market Research Report
By Type
Biochemical Inspection, Immunoassay, Pathological Diagnosis, Others
By Application
Hospital, Maternal and Child Health Hospital, Health Center, Others
By Companies
Laboratory Corporation, KingMed Diagnostics, Dian Diagnostics, Daan Gene, Adicon Clinical, BGI Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Third-party Medical Inspection Market Report Segments:
The global Third-party Medical Inspection market is segmented on the basis of:
Types
Biochemical Inspection, Immunoassay, Pathological Diagnosis, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Maternal and Child Health Hospital, Health Center, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Laboratory Corporation
- KingMed Diagnostics
- Dian Diagnostics
- Daan Gene
- Adicon Clinical
- BGI Group
Highlights of The Third-party Medical Inspection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biochemical Inspection
- Immunoassay
- Pathological Diagnosis
- Others
- By Application:
- Hospital
- Maternal and Child Health Hospital
- Health Center
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Third-party Medical Inspection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Third-party medical inspection is a process by which an independent party inspects the quality of care provided by a healthcare provider.
Some of the major players in the third-party medical inspection market are Laboratory Corporation, KingMed Diagnostics, Dian Diagnostics, Daan Gene, Adicon Clinical, BGI Group.
The third-party medical inspection market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Third-party Medical Inspection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Third-party Medical Inspection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Third-party Medical Inspection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Third-party Medical Inspection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Third-party Medical Inspection Market Size & Forecast, 2018-2028
4.5.1 Third-party Medical Inspection Market Size and Y-o-Y Growth
4.5.2 Third-party Medical Inspection Market Absolute $ Opportunity
Chapter 5 Global Third-party Medical Inspection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Third-party Medical Inspection Market Size Forecast by Type
5.2.1 Biochemical Inspection
5.2.2 Immunoassay
5.2.3 Pathological Diagnosis
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Third-party Medical Inspection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Third-party Medical Inspection Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Maternal and Child Health Hospital
6.2.3 Health Center
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Third-party Medical Inspection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Third-party Medical Inspection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Third-party Medical Inspection Analysis and Forecast
9.1 Introduction
9.2 North America Third-party Medical Inspection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Third-party Medical Inspection Market Size Forecast by Type
9.6.1 Biochemical Inspection
9.6.2 Immunoassay
9.6.3 Pathological Diagnosis
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Third-party Medical Inspection Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Maternal and Child Health Hospital
9.10.3 Health Center
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Third-party Medical Inspection Analysis and Forecast
10.1 Introduction
10.2 Europe Third-party Medical Inspection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Third-party Medical Inspection Market Size Forecast by Type
10.6.1 Biochemical Inspection
10.6.2 Immunoassay
10.6.3 Pathological Diagnosis
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Third-party Medical Inspection Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Maternal and Child Health Hospital
10.10.3 Health Center
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Third-party Medical Inspection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Third-party Medical Inspection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Third-party Medical Inspection Market Size Forecast by Type
11.6.1 Biochemical Inspection
11.6.2 Immunoassay
11.6.3 Pathological Diagnosis
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Third-party Medical Inspection Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Maternal and Child Health Hospital
11.10.3 Health Center
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Third-party Medical Inspection Analysis and Forecast
12.1 Introduction
12.2 Latin America Third-party Medical Inspection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Third-party Medical Inspection Market Size Forecast by Type
12.6.1 Biochemical Inspection
12.6.2 Immunoassay
12.6.3 Pathological Diagnosis
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Third-party Medical Inspection Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Maternal and Child Health Hospital
12.10.3 Health Center
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Third-party Medical Inspection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Third-party Medical Inspection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Third-party Medical Inspection Market Size Forecast by Type
13.6.1 Biochemical Inspection
13.6.2 Immunoassay
13.6.3 Pathological Diagnosis
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Third-party Medical Inspection Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Maternal and Child Health Hospital
13.10.3 Health Center
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Third-party Medical Inspection Market: Competitive Dashboard
14.2 Global Third-party Medical Inspection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Laboratory Corporation
14.3.2 KingMed Diagnostics
14.3.3 Dian Diagnostics
14.3.4 Daan Gene
14.3.5 Adicon Clinical
14.3.6 BGI Group
